NT_1170x120_1-11-18

generic pharmaceuticals

Amneal earns ‘Company of the Year’ honors

Amneal earns ‘Company of the Year’ honors

BRIDGEWATER, N.J. — Amneal Pharmaceuticals won the award for “Company of the Year, Americas” at the 2015 Global Generics and Biosimilars Awards held in Madrid, Spain. Amneal said late Thursday that it was the second straight year the company was recognized by Generics Bulletin, a global newsletter for the generic drug and biosimilars industries. In

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

LONDON — Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S. generic drug market, establishing the company as the sixth-largest generics maker by revenue. The addition of Roxane

Rite Aid, McKesson expand distribution relationship

Rite Aid, McKesson expand distribution relationship

CAMP HILL, Pa. — Rite Aid Corp. and McKesson Corp. have expanded their distribution agreement to cover a longer time frame and include both generic and brand-name drugs. The companies said Tuesday that the new five-year agreement runs to March 2019. The deal marks a second extension of Rite Aid and McKesson’s primary distribution relationship.